Previous Close | 448.91 |
Open | 446.60 |
Bid | 443.37 x 800 |
Ask | 446.00 x 1000 |
Day's Range | 442.03 - 447.97 |
52 Week Range | 340.49 - 461.16 |
Volume | |
Avg. Volume | 1,241,187 |
Market Cap | 139.553B |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | 50.00 |
EPS (TTM) | 8.92 |
Earnings Date | Jul 30, 2024 |
Forward Dividend & Yield | 3.64 (0.82%) |
Ex-Dividend Date | Aug 27, 2024 |
1y Target Est | 492.55 |
S&P Global's (NYSE: SPGI) second quarter 2024 results will be issued on Tuesday, July 30, 2024 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com.
Investors are in a gambling mood for S&P 500 stocks again. And it's paying off. If you invested $10,000 in January in the top-performing stock in the S&P 500 at the time and reinvested that in each month's top performer, including Caesars Entertainment in June, you'd have $49,604 now, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.